49
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Estimation of Atrazine in the Stratum Corneum and its Toxic Effects in Skin Following Topical Application to Rabbits

, , , , , , , , & show all
Pages 697-703 | Received 01 Oct 2007, Accepted 01 Nov 2007, Published online: 20 Oct 2008

REFERENCES

  • J. I. Ademola, L. E. Sedik, R. C. Wester, and H. I. Maibach. 1993. In vitro percutaneous absorption and metabolism in man of 2-chloro-4-ethylamino-6-isopropylamine-s-triazine (atrazine). Arch. Toxicol. 67:85–91.
  • M. Bashir, M. Besnard, H. Schaefer, and J. Wepierre. 2001. Stratum corneum (SC) tape stripping and water kinetic parameters utilizing three types of adhesive tapes, in vitro and in vivo randomized clinical trial. Appl. J. Dermatol. 13:48–53.
  • R. E. Baynes, J. D. Brooks, K. Budsaba, C. E. Smith, and J. E. Riviere. 2001. Mixture effects of JP-8 additives on the dermal disposition of jet fuel components. Toxicol. Appl. Pharmacol. 175:269–281.
  • J. Bouwstra, G. Pilgram, G. Gooris, H. Koerten, and M. Ponec. 2001. New aspects of skin barrier organization. Skin Pharmacol. Appl. Skin Physiol. 14:52–62.
  • R. M. Brand, and C. Mueller. 2002. Transdermal penetration of atrazine, alachlor, and trifluralin: effect of formulation. Toxicol. Sci. 68:18–23.
  • R. M. Brand, A. R. Charron, L. Dutton, T. L. Gavlik, C. Mueller, F. G. Hamel, D. Chakkalakal, and T. M. Donohue. 2004. Effects of chronic alcohol consumption on dermal penetration of pesticides in rats. J. Toxicol. Environ. Health A 67:153–161.
  • M. A. Brodkin, H. Madhoun, M. Rameswaran, and I. Vatnick. 2007. Atrazine is an immune disruptor in adult northern leopard frogs (Rana pipiens). Environ. Toxicol. Chem. 26:80–84.
  • M. Cambon, N. Issachar, D. Castelli, and C. Robert. 2001. An in vivo method to assess the photostability of UV filters in a sunscreen. J. Cosmet. Sci. 52:1–11.
  • E. H. Choi, S. H. Lee, S. K. Ahn, and S. M. Hwang. 1999. The pretreatment effect of chemicals as skin penetration enhancers in transdermal drug delivery using iontophoresis. Skin Pharmacol. Appl. Skin Physiol. 12:326–335.
  • N. M. Filipov, L. M. Pinchuk, B. L. Boyd, and P. L. Crittenden. 2005. Immunotoxic effects of short term atrazine exposure in young male C57BL/6 mice. Toxicol. Sci. 86:324–332.
  • D. W. Gammon, C. N. Aldous, W. C. CarrJr., J. R. Sanborn, and K. F. Pfeifer. 2005. A risk assessment of atrazine use in California: human health and ecological aspects. Pest. Manag. Sci. 61:331–355.
  • J. Hadgraft. 2001. Modulation of the barrier functions of the skin. Skin Pharmacol. Appl. Skin Physiol. 14:72–81.
  • Y. Ikeda, K. Hirata, S. Kano, H. Yanagihara, J. Takahara, K. Kondo, and K. I. Umemura. 2005. In vivo assessment of the cutaneous bioavailability of topically applied maxacalcitol. Methods Find Exp. Clin. Pharmacol. 27:305–310.
  • U. Jacobi, N. Meykadeh, W. Sterry, and J. Lademann. 2003. Effect of the vehicle on the amount of stratum corneum removed by tape stripping. J. Dtsch. Dermatol. Ges. 1:884–889.
  • U. Jacobi, H. J. Weigmann, M. Baumann, A. I. Reiche, W. Sterry, and J. Lademann. 2004. Lateral spreading of topically applied UV filter substances investigated by tape stripping. Skin Pharmacol. Physiol. 17:17–22.
  • A. E Jacomini, P. S. Bonato, and W. E. P. Avelar. 2003. HPLC method for the analysis of atrazine in freshwater bivalves. J. Liquid Chromatogra. Related Technol. 26:1885–1894.
  • D. Merwe, and J. E. Riviere. 2005. Comparative studies on the effects of water, ethanol and water/ethanol mixtures on chemical partitioning into porcine stratum corneum and silastic membrane. Toxicol. In Vitro 19:69–77.
  • F. Muhammad, J. D. Brooks, and J. E. Riviere. 2004. Comparative mixture effects of JP-8 (100) additives on the dermal absorption and disposition of jet fuel hydrocarbons in different membrane model systems. Toxicol. Lett. 150:351–365.
  • F. Muhammad, N. A. Monteiro-Riviere, R. E. Baynes, and J. E. Riviere. 2005a. Effect of in vivo jet fuel exposure on subsequent in vitro dermal absorption of individual aromatic and aliphatic hydrocarbon fuel constituents. J. Toxicol. Environ. Health 68:719–797.
  • F. Muhammad, N. A. Monteiro-Riviere, and J. E. Riviere. 2005b. Comparative in vivo toxicity of topical JP-8 jet fuel and its individual hydrocarbon components: identification of tridecane and tetradecane as key constituents responsible for dermal irritation. Toxicol. Pathol. 33:258–266.
  • M. O. Parat, M. J. Richard, J. C. Beani, and A. Favier. 1997. Involvement of zinc in intracellular oxidant/antioxidant balance. Biol. Trace Elem. 60:187–204.
  • J. M. Rawlings, J. Hilton, K. L. Trebilcock, B. H. Woollen, and M. F. Wilks. 1994. Effect of dosing vehicle on the dermal absorption of fluazifop-butyl and fomesafen in rats in vivo. Fundam. Appl. Toxicol. 23:93–100.
  • J. L. Rayner, R. R. Enoch, and S. E. Fenton. 2005. Adverse effects of prenatal exposure to atrazine during a critical period of mammary gland growth. Toxicol. Sci. 87:255–266.
  • A. Rougier, D. Dupuis, C. Lotte, R. Roguet, and H. Schaefer. 1983. In vivo correlation between stratum corneum reservoir function and percutaneous absorption. J. Invest. Dermatol. 81:275–278.
  • A. Rougier, C. Lotte, and H. I. Maibach. 1987. In vivo percutaneous penetration of some organic compounds related to anatomic site in humans: predictive assessment by the stripping method. J. Pharm. Sci. 76:451–454.
  • P. V. Shah, H. L. Fisher, M. R. Sumler, N. Chernoff, and L. L. Hall. 1987. Comparison of the penetration of 14 pesticides through the skin of young and adult rats. J. Toxicol. Environ. Health 2:353–366.
  • C. Surber, F. P. Schwarb, and E. W. Smith. 2001. Tape-stripping technique. J. Toxicol- Cutan. Ocular Toxicol. 20:461–474.
  • H. Weigmann, J. Lademann, and S. Schanzer. 2001. Correlation of the local distribution of topically applied substances inside the stratum corneum determined by tape-stripping to differences in bioavailability. Skin Pharamcol. Appl. Skin Physiol. 14:98–102.
  • World Health Organization. 1990. International Program on Chemical Safety, Health and Safety guide for atrazine (guide No. 47). Division of Environmental Health, WHO, Geneva

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.